Retinoid X receptor agonists enhances type I systemic and intratumoral immunity, but enhanced tumor prevention, with the HER2-IGFBP2-IGF1R plasmid vaccine in two mouse mammary tumor models

Sasha Stanton; See full list of authors in comments

Retinoid X receptor agonists enhances type I systemic and intratumoral immunity, but enhanced tumor prevention, with the HER2-IGFBP2-IGF1R plasmid vaccine in two mouse mammary tumor models

Sasha Stanton, See full list of authors in comments

Research output: Other contribution

Original language	Undefined/Unknown
State	Published - Nov 1 2023

Publication series

Name	Articles, Abstracts, and Reports

Access to Document

http://digitalcommons.providence.org/publications/8367

Cite this

@misc{3522c1fe25a445708d78d8733cdfef55,

title = "Retinoid X receptor agonists enhances type I systemic and intratumoral immunity, but enhanced tumor prevention, with the HER2-IGFBP2-IGF1R plasmid vaccine in two mouse mammary tumor models",

author = "Sasha Stanton and comments, {See full list of authors in}",

year = "2023",

month = nov,

day = "1",

language = "Undefined/Unknown",

series = "Articles, Abstracts, and Reports",

type = "Other",

}